Keyphrases
P-glycoprotein (P-gp)
100%
Protease Inhibitors
100%
Hypoxia
100%
Drug Resistance
100%
Myeloma Cells
100%
Tariquidar
100%
Hypoxia-inducible factor-1α (HIF-1α)
50%
P-glycoprotein Inhibitor
50%
Multiple Myeloma Patients
50%
P-glycoprotein Expression
50%
Chemoresistance
25%
Protein Expression
25%
Drug Transporters
25%
Poor Prognosis
25%
Bone Marrow Niche
25%
Multiple Myeloma
25%
Bortezomib
25%
Flow Cytometry
25%
Myeloma
25%
Efflux
25%
Via Resistance
25%
Carfilzomib
25%
Multiple Myeloma Progression
25%
P-glycoprotein Substrate
25%
P-glycoprotein Activity
25%
Hypoxia-inducible Transcription Factor
25%
Hypoxic Markers
25%
Post-chemotherapy
25%
High Lethality
25%
Medicine and Dentistry
Drug Resistance
100%
ABC Transporter Subfamily B
100%
Multiple Myeloma
100%
Hypoxia
100%
Proteasome Inhibitor
100%
Myeloma Cell
100%
Tariquidar
100%
Effusion
25%
In Vitro
12%
Clinical Study
12%
Protein Expression
12%
Flow Cytometry
12%
Transcription Factors
12%
Lethality
12%
Myeloma
12%
Bortezomib
12%
Carfilzomib
12%
Glycoprotein P Inhibitor
12%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
100%
Hypoxia
100%
Drug Resistance
100%
P-Glycoprotein
100%
Proteasome Inhibitor
100%
Tariquidar
100%
Effusion
25%
Lethality
12%
Clinical Study
12%
Chemotherapy
12%
Bortezomib
12%
Transcription Factors
12%
Flow Cytometry
12%
Myeloma
12%
Carfilzomib
12%
Glycoprotein P Inhibitor
12%
Immunology and Microbiology
Drug Resistance
100%
Multiple Myeloma
100%
Proteasome
100%
P-Glycoprotein
100%
Myeloma Cell
100%
Transcription Factors
11%
Protein Expression
11%
Biochemistry, Genetics and Molecular Biology
Drug Resistance
100%
Proteasome Inhibitor
100%
P-Glycoprotein
100%
Transcription Factors
11%
Protein Expression
11%
Clinical Study
11%
Flow Cytometry
11%